NES
AGN

New England Securities’s Allergan Inc AGN Stock Holding History

New England Securities’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$30K Sell
142
-11
-7% -$2.19K 0.01% 750
2014
Q3 		$27K Sell
153
-65
-30% -$10.8K 0.01% 816
2014
Q2 		$37K Buy
218
+125
+134% +$19.5K 0.01% 706
2014
Q1 		$12K Sell
93
-134
-59% -$16.3K ﹤0.01% 1031
2013
Q4 		$25K Sell
227
-70
-24% -$6.69K 0.01% 762
2013
Q3 		$27K Buy
297
+42
+16% +$3.77K 0.01% 682
2013
Q2 		$21K Buy
+255
New +$26.5K 0.01% 677

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

New England Securities's AGN Position: Q4 2014 in Review

New England Securities reduced its Allergan Inc (AGN) stake by 7.2% in Q4 2014, selling an estimated $2.19K and leaving 142 shares worth $30K. The position accounts for 0.01% of the portfolio, ranked #750.

New England Securities first reported a position in AGN in Q2 2013 and has held it in 7 quarters since. The position peaked at $37K in Q2 2014. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • New England Securities held 142 shares of Allergan Inc worth $30K as of Q4 2014.
  • New England Securities sold 11 Allergan Inc shares in Q4 2014, an estimated $2.19K.
  • Allergan Inc made up 0.01% of New England Securities's portfolio in Q4 2014, its #750 holding.
  • New England Securities first reported a position in Allergan Inc in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's Allergan Inc position peaked at $37K in Q2 2014.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.